VOR
Vor Biopharma Inc.After hours19.06−0.74 −3.74%USD
NasdaqGS · as of Oct 13, 16:00 ET · 15m delayAfter hours 18.75 −1.63%
Open
19.50
Prev close
19.80
Day range
18.9819.95
52-week range
6.5033.42
Volume
949.42K0.98×
Mkt cap
1.13B
P/E ttm
0.11
Fwd P/E
-5.02
EPS ttm
180.18
Div yield
0.00%
Earnings
Aug 11, 2026
From 52w high
−42.97%
VOR earnings and estimates
VOR Next Report
Yahoo Finance · Nasdaq
Report date
Thu, Nov 12
During market hours · estimated
EPS consensus
$−0.72
range −0.72 – −0.72
EPS growth vs year ago
+99.4%
year ago −121.63
Revenue consensus
$0
0.0% vs year ago
Options-implied move
±27.8%
by Nov 20 · ATM straddle
Past 4 reactions
±2.1%
average move · beat 2 of 4
EPS: Actual vs Estimate
Price Reaction
close before → close after the report
Recent Reports
| Quarter ending | Reported | EPS | Estimate | Surprise | Revenue | Next session | Five sessions |
|---|---|---|---|---|---|---|---|
| Jun '26 | Aug 11, 2026 Intraday | −0.80 | −0.70 | −13.97% | $0 | +0.9% | −1.5% |
| Mar '26 | May 13, 2026 BMO | −0.73 | −0.78 | +7.22% | $0 | −3.4% | −14.2% |
| Dec '25 | Mar 30, 2026 BMO | 307.53 | −1.19 | +25920.29% | $0 | +1.5% | +12.4% |
| Sep '25 | Nov 13, 2025 AMC | −121.63 | −4.10 | −2866.59% | $0 | +2.7% | −29.6% |
Consensus Estimates and Revisions
| Period | EPS | Low · range · high | Growth | Revenue | Growth | 30d ago | 90d ago | Up / down (30d) |
|---|---|---|---|---|---|---|---|---|
| Current quarter Sep 2026 | −0.72 | — | +99.4% | $0 | 0.0% | −0.72 0.0% | −0.77 +6.2% | 1 / 1 |
| Next quarter Dec 2026 | −0.77 | — | −100.3% | $0 | 0.0% | −0.77 0.0% | −0.93 +17.4% | 1 / 1 |
| Current year Dec 2026 | −6.53 | — | +90.7% | $0 | 0.0% | −6.53 0.0% | −6.90 +5.4% | 1 / 1 |
| Next year Dec 2027 | −3.80 | −4.50−2.93 | +41.8% | $0 | 0.0% | −3.81 +0.4% | −3.74 −1.5% | 1 / 1 |
The change columns show how the consensus has moved since then; steady upward revisions often precede beats. Ranges place the consensus between the lowest and highest analyst estimate.
Forward EPS Forecasts
Nasdaq · Zacks consensus
Quarterly
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Sep 2026 | −0.81 | −0.91−0.75 | 4 | 0 / 0 |
| Dec 2026 | −0.84 | −0.94−0.77 | 5 | 0 / 0 |
| Mar 2027 | −0.81 | −0.90−0.74 | 3 | 0 / 0 |
| Jun 2027 | −0.30 | −0.870.81 | 3 | 0 / 0 |
| Sep 2027 | −0.85 | −0.89−0.78 | 3 | 0 / 0 |
Fiscal years
| Fiscal period | Consensus | Low · range · high | Analysts | Up / down (4w) |
|---|---|---|---|---|
| Dec 2026 | −2.56 | −3.19−2.20 | 3 | 0 / 0 |
| Dec 2027 | −3.43 | −3.65−2.93 | 5 | 0 / 0 |
| Dec 2028 | −3.62 | −4.97−2.61 | 4 | 0 / 0 |
| Dec 2029 | −1.53 | −3.031.33 | 3 | 0 / 0 |
Reactions run from the last close before a report to the first close after it (an after-the-close report is measured to the next day's close). The implied move is the at-the-money straddle for the first expiry after the report, the same rule as the bot's lgf emove.